Lineage Cell Therapeutics Provides Update on Renevia® Commercialization Plans
Go back to Lineage Cell Therapeutics Provides Update on Renevia® Commercialization Plans| (NYSE: LCTX) | Delayed: 0.96 -0.02 (2.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.98 | 52 Week High | $ | |||
| Open | $0.98 | 52 Week Low | $ | |||
| Day High | $1.00 | P/E | N/A | |||
| Day Low | $0.94 | EPS | $ | |||
| Volume | 752,821 | |||||
| (NYSE: LCTX) | Delayed: 0.96 -0.02 (2.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.98 | 52 Week High | $ | |||
| Open | $0.98 | 52 Week Low | $ | |||
| Day High | $1.00 | P/E | N/A | |||
| Day Low | $0.94 | EPS | $ | |||
| Volume | 752,821 | |||||



